X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5988) 5988
Publication (749) 749
Newsletter (362) 362
Book Review (98) 98
Magazine Article (51) 51
Newspaper Article (35) 35
Book Chapter (34) 34
Conference Proceeding (12) 12
Dissertation (8) 8
Web Resource (6) 6
Reference (4) 4
Trade Publication Article (3) 3
Book / eBook (2) 2
Streaming Video (2) 2
Data Set (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3916) 3916
bupropion (3654) 3654
male (2290) 2290
female (2077) 2077
index medicus (2044) 2044
adult (1734) 1734
bupropion - therapeutic use (1567) 1567
psychiatry (1441) 1441
smoking cessation (1340) 1340
middle aged (1324) 1324
pharmacology & pharmacy (1271) 1271
smoking cessation - methods (1234) 1234
sustained-release bupropion (1093) 1093
smoking (954) 954
treatment outcome (897) 897
varenicline (854) 854
nicotine (703) 703
smoking cessation programs (692) 692
animals (640) 640
bupropion - adverse effects (633) 633
antidepressants (574) 574
bupropion - administration & dosage (571) 571
double-blind (562) 562
neurosciences (555) 555
research (555) 555
receptor partial agonist (554) 554
depression (546) 546
drug therapy (542) 542
antidepressive agents, second-generation - therapeutic use (539) 539
substance abuse (537) 537
aged (536) 536
adolescent (530) 530
smoking-cessation (525) 525
cessation (517) 517
medicine, general & internal (506) 506
article (488) 488
placebo (484) 484
randomized controlled-trial (481) 481
double-blind method (477) 477
nicotine replacement therapy (471) 471
pharmacotherapy (454) 454
dopamine uptake inhibitors - therapeutic use (447) 447
bupropion - pharmacology (445) 445
smokers (443) 443
tobacco (440) 440
care and treatment (426) 426
antidepressive agents - therapeutic use (401) 401
efficacy (392) 392
nicotinic agonists - therapeutic use (383) 383
smoking prevention (378) 378
risk factors (375) 375
analysis (370) 370
cigarette-smoking (367) 367
tobacco use disorder - drug therapy (365) 365
dose-response relationship, drug (363) 363
rats (355) 355
health aspects (353) 353
nicotine - administration & dosage (350) 350
psychology, clinical (337) 337
drugs (336) 336
depressive disorder - drug therapy (335) 335
young adult (334) 334
drug therapy, combination (326) 326
clinical neurology (325) 325
public, environmental & occupational health (323) 323
benzazepines - therapeutic use (315) 315
dependence (313) 313
dopamine (312) 312
nicotine - therapeutic use (305) 305
placebo-controlled trial (298) 298
quinoxalines - therapeutic use (296) 296
antidepressive agents, second-generation - adverse effects (289) 289
smoking - drug therapy (286) 286
smoking cessation - psychology (275) 275
usa (275) 275
clinical trials (272) 272
delayed-action preparations (264) 264
dosage and administration (260) 260
nicotine dependence (259) 259
major depression (251) 251
depressive disorder, major - drug therapy (244) 244
smoking - epidemiology (237) 237
depression, mental (234) 234
smoking - psychology (234) 234
time factors (233) 233
fluoxetine (232) 232
drug interactions (229) 229
comorbidity (227) 227
therapy (225) 225
follow-up studies (222) 222
medicine & public health (220) 220
antidepressant (219) 219
mental disorders (217) 217
antidepressive agents - adverse effects (215) 215
abridged index medicus (214) 214
usage (212) 212
randomized controlled trials as topic (211) 211
counseling (207) 207
major depressive disorder (207) 207
pharmacology (206) 206
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6069) 6069
Spanish (112) 112
German (93) 93
French (71) 71
Turkish (24) 24
Polish (17) 17
Portuguese (16) 16
Korean (10) 10
Dutch (9) 9
Italian (8) 8
Japanese (8) 8
Czech (7) 7
Danish (7) 7
Norwegian (7) 7
Chinese (5) 5
Hungarian (4) 4
Russian (4) 4
Swedish (4) 4
Hebrew (2) 2
Persian (2) 2
Finnish (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biophysical Journal, ISSN 0006-3495, 01/2015, Volume 108, Issue 2, p. 433
Journal Article
Der Nervenarzt, ISSN 0028-2804, 11/2017, Volume 88, Issue 11, p. 1320
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00115-016-0200-3 
Bupropion
Journal Article
Clinical Biochemistry, ISSN 0009-9120, 06/2014, Volume 47, Issue 9, pp. 769 - 769
Journal Article
The American Journal on Addictions, ISSN 1055-0496, 03/2013, Volume 22, Issue 2, p. 180
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 09/2014, Volume 96, Issue 3, pp. 349 - 359
The suitability of the capillary dried blood spot (DBS) sampling method was assessed for simultaneous phenotyping of cytochrome P450 (CYP) enzymes and... 
P4502B6 ACTIVITY | VORICONAZOLE | LC-MS/MS | SINGLE-POINT | ORAL MIDAZOLAM | VOLUNTEERS | IN-VIVO | PHARMACOLOGY & PHARMACY | DRUG-METABOLIZING-ENZYMES | KAROLINSKA COCKTAIL | BUPROPION HYDROXYLATION | Predictive Value of Tests | Pharmaceutical Preparations - blood | Caffeine - administration & dosage | Cytochrome P-450 Enzyme Inhibitors | Dried Blood Spot Testing | Humans | Omeprazole - blood | Bupropion - blood | Midazolam - administration & dosage | Substrate Specificity | Male | Chromatography, High Pressure Liquid | ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors | Coffee | Terfenadine - administration & dosage | Caffeine - pharmacokinetics | Feasibility Studies | Enzyme Inhibitors - administration & dosage | Young Adult | Chromatography, Reverse-Phase | Tandem Mass Spectrometry | Capsules | Spectrometry, Mass, Electrospray Ionization | Flurbiprofen - administration & dosage | Adult | Dextromethorphan - pharmacokinetics | Terfenadine - blood | ATP-Binding Cassette, Sub-Family B, Member 1 - blood | Pharmaceutical Preparations - administration & dosage | Terfenadine - pharmacokinetics | Bupropion - pharmacokinetics | Flurbiprofen - pharmacokinetics | Cytochrome P-450 Enzyme System - blood | Administration, Oral | Isoenzymes | Caffeine - blood | Omeprazole - administration & dosage | Terfenadine - analogs & derivatives | Omeprazole - pharmacokinetics | Carbonated Beverages | Midazolam - pharmacokinetics | Bupropion - administration & dosage | Dextromethorphan - blood | Flurbiprofen - blood | Phenotype | Pilot Projects | Midazolam - blood | Dextromethorphan - administration & dosage | Usage | Glycoproteins | Liquid chromatography | Research | Pharmacokinetics | Cytochrome P-450 | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 08/2016, Volume 358, Issue 2, pp. 230 - 238
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2016, Volume 2016, Issue 5, p. CD006103
Background Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract... 
Smoking [drug therapy] | Varenicline | Humans | RANDOMIZED CONTROLLED-TRIAL | Quinolizines [therapeutic use] | PSYCHIATRIC ADVERSE EVENTS | TOBACCO-DEPENDENCE TREATMENT | Quinoxalines [therapeutic use] | MEDICINE, GENERAL & INTERNAL | Bupropion [therapeutic use] | Nicotine [adverse effects; antagonists & inhibitors] | REPLACEMENT THERAPY | SUSTAINED-RELEASE BUPROPION | Smoking Cessation [methods] | Counseling [methods] | VARENICLINE TREATMENT | METHADONE-MAINTAINED SMOKERS | Randomized Controlled Trials as Topic | Azepines [therapeutic use] | DOUBLE-BLIND PLACEBO | Alkaloids [therapeutic use] | Nicotinic Agonists [adverse effects; therapeutic use] | Azocines [therapeutic use] | LONG-TERM SAFETY | Benzazepines [therapeutic use] | PLACEBO-CONTROLLED TRIAL | Substance Withdrawal Syndrome [prevention & control] | Heterocyclic Compounds with 4 or More Rings [therapeutic use] | Quinolizines - therapeutic use | Azepines - adverse effects | Azocines - therapeutic use | Azocines - adverse effects | Substance Withdrawal Syndrome - prevention & control | Alkaloids - adverse effects | Benzazepines - adverse effects | Smoking - drug therapy | Heterocyclic Compounds, 4 or More Rings - adverse effects | Nicotinic Agonists - therapeutic use | Nicotine - antagonists & inhibitors | Smoking Cessation - methods | Azepines - therapeutic use | Nicotine - adverse effects | Nicotinic Agonists - adverse effects | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Benzazepines - therapeutic use | Counseling - methods | Alkaloids - therapeutic use | Quinolizines - adverse effects | Varenicline - therapeutic use | Bupropion - therapeutic use
Journal Article
Circulation, ISSN 0009-7322, 01/2014, Volume 129, Issue 1, pp. 28 - 41
Journal Article
Comprehensive Psychiatry, ISSN 0010-440X, 09/2019, p. 152125
Journal Article
Journal Article